Baxter International Inc. (BAX), headquartered in Deerfield, Illinois, develops and provides a portfolio of healthcare ...

Baxter International stock has reached a new 52-week low, touching $17.26, with shares currently trading at $17.24 and a market capitalization of $9.1 billion. This milestone refl ...

Baxter's fourth quarter of 2025 saw total sales rise 8% year over year to $2.97 billion. The company's net income from continuing operations not in accordance with generally accepted accounting ...

Shares of Baxter International Inc. BAX slipped 1.84% to $17.08 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.01% to 6, ...

Baxter International BAX recently announced the launch of five new injectable pharmaceutical products in the United States, which, when combined with the previous five launches announced in April 2024 ...

With its Q3 2024 results on Friday, Baxter International (NYSE:BAX) lowered its outlook to reflect a roughly $200M revenue impact attributed to Hurricane Helene in North Carolina, which forced the ...

Baxter International beat Wall Street estimates today, and shares surged as the medical equipment company projected healthy growth next year following the completion of a massive restructuring plan.

Its final quarter of 2025 was mixed, with a notable whiff on earnings. On the plus side, it notched a convincing beat on revenue. Baxter's fourth quarter of 2025 saw total sales rise 8% year over year ...

Baxter International Inc. closed 46.05% short of its 52-week high of $37.74, which the company reached on March 10th.